TABLE 1.
Variables | EF ≥50% (N=741) | EF <50% (N=1094) | P-value |
---|---|---|---|
Ejection Fraction, % | 57.2 ±5.4 | 28.6 ±11.3 | |
Age, years | 71.3 ±12.3 | 67.5 ±13.6 | 0.001 |
Female | 449 (60.6%) | 451 (41.2%) | 0.001 |
African American | 357 (48.2%) | 618 (56.5%) | 0.001 |
Atrial Fibrillation | 221 (29.8%) | 281 (25.7%) | 0.051 |
Diabetes | 344 (46.4%) | 443 (40.5%) | 0.012 |
Hypertension | 544 (73.4%) | 669 (61.2%) | 0.001 |
COPD | 289 (39.0%) | 3.14 (28.7%) | 0.001 |
Peripheral Vascular Disease | 105 (14.2%) | 140 (12.8%) | 0.396 |
Cerebrovascular Accident | 112 (15.1%) | 149 (13.6%) | 0.368 |
Previous Heart Failure | 322 (43.5%) | 545 (49.8%) | 0.007 |
Chronic Kidney Disease | 94 (12.7%) | 106 (9.7%) | 0.043 |
Coronary Artery Disease | 189 (25.5%) | 348 (31.8%) | 0.004 |
Baseline Sodium, meq/dl | 139.6 ±4.1 | 139.6±4.1 | 0.372 |
ACE Inhibitor/ARB Exposure | 0.26 ±0.30 | 0.26 ±0.27 | 0.049 |
Beta Blocker Exposure | 0.24 ±0.28 | 0.24 ±0.27 | 0.198 |